CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,595,000 | -94.5% | 30,900 | -97.4% | 0.00% | -95.0% |
| Q2 2022 | $29,214,000 | -16.7% | 1,178,948 | -15.7% | 0.06% | -9.1% |
| Q1 2022 | $35,064,000 | +16.2% | 1,398,583 | +68.7% | 0.07% | +17.9% |
| Q4 2021 | $30,184,000 | +333.6% | 828,998 | +585.1% | 0.06% | +14.3% |
| Q2 2020 | $6,962,000 | +1332.5% | 121,003 | +901.3% | 0.05% | +880.0% |
| Q1 2020 | $486,000 | -76.5% | 12,084 | -76.9% | 0.01% | -64.3% |
| Q4 2019 | $2,067,000 | -43.8% | 52,270 | -80.3% | 0.01% | -17.6% |
| Q1 2019 | $3,680,000 | +115.2% | 264,820 | -6.3% | 0.02% | -19.0% |
| Q3 2015 | $1,710,000 | -26.5% | 282,713 | 0.0% | 0.02% | -30.0% |
| Q2 2015 | $2,327,000 | +35.4% | 282,713 | +24.2% | 0.03% | +36.4% |
| Q1 2015 | $1,719,000 | +199.0% | 227,658 | +131.6% | 0.02% | +175.0% |
| Q2 2014 | $575,000 | – | 98,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |